Highlights of ASH in CLL
John Gribben et al.
Inotuzumab ozogamicin for the treatment of elderly acute lymphoblastic leukemia
Obinutuzumab (GA101) plus bendamustine as front-line therapy in CLL
Transplant vs bortezomib and LEN/DEX in multiple myeloma
Adopting new cancer treatments by continuing medical education